S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:NOVN

Novan Stock Forecast, Price & News

$1.45
+0.08 (+5.84 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.12
Now: $1.45
$1.48
50-Day Range
$1.00
MA: $1.60
$2.55
52-Week Range
$0.28
Now: $1.45
$2.59
Volume9.71 million shs
Average Volume22.20 million shs
Market Capitalization$218.65 million
P/E RatioN/A
Dividend YieldN/A
Beta0.01
Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide's natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.
Novan logo

Headlines

Form 8-K Novan, Inc. For: Jan 18 - StreetInsider.com
January 19, 2021 |  streetinsider.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NOVN
CUSIPN/A
Phone(919) 485-8080
Employees24
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.90 million
Book Value($0.89) per share

Profitability

Net Income$-30,640,000.00
Net Margins-379.35%

Miscellaneous

Market Cap$218.65 million
Next Earnings Date5/19/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.87 out of 5 stars

Medical Sector

987th out of 1,972 stocks

Pharmaceutical Preparations Industry

463rd out of 772 stocks

Analyst Opinion: 1.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$1.45
+0.08 (+5.84 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NOVN News and Ratings via Email

Sign-up to receive the latest news and ratings for NOVN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Novan (NASDAQ:NOVN) Frequently Asked Questions

Is Novan a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Novan stock.
View analyst ratings for Novan
or view top-rated stocks.

What stocks does MarketBeat like better than Novan?

Wall Street analysts have given Novan a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Novan wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Novan's next earnings date?

Novan is scheduled to release its next quarterly earnings announcement on Wednesday, May 19th 2021.
View our earnings forecast for Novan
.

How were Novan's earnings last quarter?

Novan, Inc. (NASDAQ:NOVN) issued its quarterly earnings results on Friday, October, 30th. The company reported ($0.06) EPS for the quarter, hitting the Zacks' consensus estimate of ($0.06). The company had revenue of $1.32 million for the quarter, compared to the consensus estimate of $1.24 million.
View Novan's earnings history
.

How has Novan's stock been impacted by COVID-19?

Novan's stock was trading at $0.52 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NOVN stock has increased by 178.8% and is now trading at $1.45.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for NOVN?

1 equities research analysts have issued twelve-month price objectives for Novan's shares. Their forecasts range from $1.50 to $1.50. On average, they anticipate Novan's share price to reach $1.50 in the next year. This suggests a possible upside of 3.4% from the stock's current price.
View analysts' price targets for Novan
or view top-rated stocks among Wall Street analysts.

Who are Novan's key executives?

Novan's management team includes the following people:
  • Paula Brown Stafford, Chairman, President & Chief Executive Officer
  • John M. Gay, Chief Financial Officer, Secretary & VP
  • Carri Geer, Chief Technology Officer & Senior Vice President
  • Elizabeth Messersmith, Chief Development Officer & Senior Vice President
  • Tomoko Maeda-Chubachi, Vice President-Medical Dermatology

Who are some of Novan's key competitors?

What other stocks do shareholders of Novan own?

When did Novan IPO?

(NOVN) raised $46 million in an IPO on Wednesday, September 21st 2016. The company issued 3,800,000 shares at $11.00-$13.00 per share. Piper Jaffray served as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

What is Novan's stock symbol?

Novan trades on the NASDAQ under the ticker symbol "NOVN."

Who are Novan's major shareholders?

Novan's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (2.43%), Northern Trust Corp (0.20%), Captrust Financial Advisors (0.08%), HighTower Advisors LLC (0.03%) and Prospera Financial Services Inc (0.03%). Company insiders that own Novan stock include G Kelly Martin, John M Gay, John W Palmour, Life Sciences Holdings L Malin, Paula B Stafford and Robert Alexander Ingram.
View institutional ownership trends for Novan
.

Which major investors are selling Novan stock?

NOVN stock was sold by a variety of institutional investors in the last quarter, including Prospera Financial Services Inc.
View insider buying and selling activity for Novan
or view top insider-selling stocks.

Which major investors are buying Novan stock?

NOVN stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Northern Trust Corp, Captrust Financial Advisors, and HighTower Advisors LLC. Company insiders that have bought Novan stock in the last two years include G Kelly Martin, John M Gay, John W Palmour, Paula B Stafford, and Robert Alexander Ingram.
View insider buying and selling activity for Novan
or or view top insider-buying stocks.

How do I buy shares of Novan?

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novan's stock price today?

One share of NOVN stock can currently be purchased for approximately $1.45.

How much money does Novan make?

Novan has a market capitalization of $218.65 million and generates $4.90 million in revenue each year. The company earns $-30,640,000.00 in net income (profit) each year or ($0.80) on an earnings per share basis.

How many employees does Novan have?

Novan employs 24 workers across the globe.

What is Novan's official website?

The official website for Novan is www.novan.com.

Where are Novan's headquarters?

Novan is headquartered at 4105 HOPSON ROAD, MORRISVILLE NC, 27560.

How can I contact Novan?

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 485-8080 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.